This Cannabis Stock Is Building Something Truly Special

The cannabis opportunity is too good to pass up, but not every stock will make you rich. Discover what makes Hexo Corp. (TSX:HEXO)(NYSE:HEXO) a winning bet.

| More on:
Cannabis stocks have fallen.

The cannabis opportunity is unlike any other. Multi-billion-dollar markets rarely appear virtually overnight. Both novice and veteran investors alike have the chance to get rich.

Just don’t assume that every cannabis stock will put you on the road to riches. Think back to the dot-com bubble of the 1990s. There were literally hundreds of internet stocks to invest in. Two decades later, the internet is larger than we ever imagined, but the vast majority of those former winners no longer exist. Often, investors lost everything.

Yet several of the most valuable companies in the world were launched during the bubble, including legendary stocks like Microsoft and Amazon.com. Pick the right stocks and financial independence can be yours.

Looking at the cannabis market today, you have plenty of investable options. Which stock should you trust with your money? If you want truly lucrative upside, there’s one clear choice.

Build something different

The cannabis market is growing fast. This we know. We also know that there’s a high probability that it will continue to grow for years, maybe even decades. Market demand has always spiked wherever marijuana has been made legal. With dozens of large markets — not to mention the biggest of all, the U.S. — still lacking federal legalization, the largest growth dominoes are yet to fall.

Yet as we saw with the dot-com bubble, being in a high-growth industry is no guarantee of success. The biggest hurdle that plagues cannabis companies is oversupply. Last year, I warned that commoditization was the biggest risk pot investors faced, even if few analysts were talking about it. This summer, Tilray helped tip off the cannabis bear market after it reported a big decline in selling prices.

Pricing pressure will only worsen. Nearly every cannabis producer still plans to ramp production further in 2020. If you want to succeed, you need to do more than grow pot.

Platforms will win

Earlier, I mentioned how Amazon and Microsoft were some of the only companies to not only survive the dot-com bubble but thrive in the years following it. What do they have in common? Both are platform companies.

Platform businesses allow other businesses to build on top of them. Application developers can build on top of Windows, while online merchants can build on top of Amazon’s marketplace. If you take away the underlying platforms, everything that is built on top disappears. That’s the power of platforms, enabling sky-high customer-retention rates and lucrative network effects.

Hexo (TSX:HEXO)(NYSE:HEXO) is applying the same approach to cannabis, something no other competitor is pursuing.

Instead of simply growing weed or packaging it to create its own brands, HEXO is building the base infrastructure for other businesses to build on top of. This year, it wrapped up construction of a grow facility, research and development centre, as well as a processing, packaging, and distribution facility. Other companies can then tap into this infrastructure to spin up their own cannabis products.

HEXO has already secured pilot partners. This month, its venture with Molson Coors Canada will launch its first cannabis-infused beverage. What’s more likely to succeed: a new Molson beverage or a beverage from an unknown pot startup? HEXO is betting on the former.

In 2020, HEXO is looking to secure additional partnerships in new verticals like cosmetics, sleep aids, and edibles. If it can validate its cannabis platform model, HEXO could easily become one of the best-performing pot stocks on the market. This is your chance to buy the Amazon and Microsoft of weed.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool’s board of directors. David Gardner owns shares of Amazon. The Motley Fool owns shares of and recommends Amazon and Microsoft. The Motley Fool owns shares of Molson Coors Brewing. The Motley Fool recommends HEXO. and HEXO and recommends the following options: long January 2021 $85 calls on Microsoft. John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool’s board of directors. David Gardner owns shares of Amazon. The Motley Fool owns shares of and recommends Amazon and Microsoft. The Motley Fool owns shares of Molson Coors Brewing. The Motley Fool recommends HEXO. and HEXO and recommends the following options: long January 2021 $85 calls on Microsoft. Fool contributor Ryan Vanzo has no position in any stocks mentioned. 

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »